Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunder Mudaliar

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Journal of the Indian Institute of Science|February 27, 2023
The Evolution of Diabetes Treatment Through the Ages: From Starvation Diets to Insulin, Incretins, SGLT2-Inhibitors and BeyondSunder Mudaliar
Expert Opinion on Investigational Drugs|October 10, 2007
Inhaled insulin using AERx insulin Diabetes Management System (AERx iDMS)Sunder Mudaliar
The Indian Journal of Medical Research|May 15, 2007
New frontiers in the management of type 2 diabetesSunder Mudaliar
Cardiovascular Endocrinology & Metabolism|October 25, 2019
Integrating cardioprotective glucose-lowering medications into clinical practiceSunder Mudaliar
Current Atherosclerosis Reports|August 12, 2009
Serum glucose control in diabetic patients with cardiovascular disease: should we be less aggressive?Sunder Mudaliar
Journal of Clinical Pharmacology|March 31, 2004
Intense management of diabetes mellitus: role of glucose control and antiplatelet agentsSunder Mudaliar
Diabetes, Obesity & Metabolism|April 9, 2019
Navigating the "MACE" in Cardiovascular Outcomes Trials and decoding the relevance of Atherosclerotic Cardiovascular Disease benefits versus Heart Failure benefitsChristopher Hupfeld, Sunder Mudaliar
Diabetes & Metabolic Syndrome|January 19, 2023
Increase in hematocrit with SGLT-2 inhibitors - Hemoconcentration from diuresis or increased erythropoiesis after amelioration of hypoxia?Preethika Ekanayake, Sunder Mudaliar
The Indian Journal of Medical Research|May 9, 2022
Changing the diabetes treatment paradigm from glucose control to cardiorenal protectionPreethika Ekanayake, Sunder Mudaliar
Diabetes, Obesity & Metabolism|October 4, 2021
A novel hypothesis linking low-grade ketonaemia to cardio-renal benefits with sodium-glucose cotransporter-2 inhibitorsPreethika Ekanayake, Sunder Mudaliar
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Journal of the Indian Institute of Science|February 27, 2023
The Evolution of Diabetes Treatment Through the Ages: From Starvation Diets to Insulin, Incretins, SGLT2-Inhibitors and BeyondSunder Mudaliar
Expert Opinion on Investigational Drugs|October 10, 2007
Inhaled insulin using AERx insulin Diabetes Management System (AERx iDMS)Sunder Mudaliar
The Indian Journal of Medical Research|May 15, 2007
New frontiers in the management of type 2 diabetesSunder Mudaliar
Cardiovascular Endocrinology & Metabolism|October 25, 2019
Integrating cardioprotective glucose-lowering medications into clinical practiceSunder Mudaliar
Current Atherosclerosis Reports|August 12, 2009
Serum glucose control in diabetic patients with cardiovascular disease: should we be less aggressive?Sunder Mudaliar
Journal of Clinical Pharmacology|March 31, 2004
Intense management of diabetes mellitus: role of glucose control and antiplatelet agentsSunder Mudaliar
Diabetes, Obesity & Metabolism|April 9, 2019
Navigating the "MACE" in Cardiovascular Outcomes Trials and decoding the relevance of Atherosclerotic Cardiovascular Disease benefits versus Heart Failure benefitsChristopher Hupfeld, Sunder Mudaliar
Diabetes & Metabolic Syndrome|January 19, 2023
Increase in hematocrit with SGLT-2 inhibitors - Hemoconcentration from diuresis or increased erythropoiesis after amelioration of hypoxia?Preethika Ekanayake, Sunder Mudaliar
The Indian Journal of Medical Research|May 9, 2022
Changing the diabetes treatment paradigm from glucose control to cardiorenal protectionPreethika Ekanayake, Sunder Mudaliar
Diabetes, Obesity & Metabolism|October 4, 2021
A novel hypothesis linking low-grade ketonaemia to cardio-renal benefits with sodium-glucose cotransporter-2 inhibitorsPreethika Ekanayake, Sunder Mudaliar
Pageof 9